Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme

Radiotherapy and Oncology

Volumn 101, Issue 1, 2011, Pages 127-131

  Kase, Marju ^a   Vardja, Markus ^b   Lipping, Agu ^a   Asser, Toomas ^b,c   Jaal, Jana ^b,c  

^a North Estonia Medical Centre   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

DNA PK; Glioblastoma multiforme; PARP 1; Postoperative radiotherapy; Survival

Indexed keywords

DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN KINASE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR VOLUME;

BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; COHORT STUDIES; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DOSE FRACTIONATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; NEUROSURGICAL PROCEDURES; POLY(ADP-RIBOSE) POLYMERASES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80655144397     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.024     Document Type: Article

References (43)

1. E.G. Van Meir, C.G. Hadjipanayis, A.D. Norden, H.K. Shu, P.Y. Wen, and J.J. Olson Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma CA Cancer J Clin 60 2010 166 193
2. M.D. Walker, E. Alexander Jr., and W.E. Hunt Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J Neurosurg 49 1978 333 343 (Pubitemid 9013313)
3. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018 (Pubitemid 34286538)
4. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
5. G. Filippini, C. Falcone, and A. Boiardi Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma Neuro Oncol 10 2008 79 87 (Pubitemid 351250903)
6. D.C. Weber, N. Casanova, and T. Zilli Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study Radiother Oncol 93 2009 586 592
7. G. Minniti, D. Amelio, and M. Amichetti Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide Radiother Oncol 97 2010 377 381
8. M.T. Milano, P. Okunieff, and R.S. Donatello Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma Int J Radiat Oncol Biol Phys 78 2010 1147 1155
9. J.L. Chan, S.W. Lee, and B.A. Fraass Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J Clin Oncol 20 2002 1635 1642 (Pubitemid 34260545)
10. F. Dumont, A. Altmeyer, and P. Bischoff Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches Expert Opin Ther Pat 19 2009 775 799
11. T. McMillan, and G. Steel DNA damage and cell killing G. Steel, Basic Clinical Radiobiology 3rd ed. 2002 Arnold London 71 83
12. P.L. Olive The role of DNA single- and double-strand breaks in cell killing by ionizing radiation Radiat Res 150 1998 S42 S51
13. J.C. Ame, C. Spenlehauer, and G. de Murcia The PARP superfamily Bioessays 26 2004 882 893 (Pubitemid 39128102)
14. A.E. Fisher, H. Hochegger, S. Takeda, and K.W. Caldecott Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase Mol Cell Biol 27 2007 5597 5605 (Pubitemid 47124411)
15. A.J. Chalmers The potential role and application of PARP inhibitors in cancer treatment Br Med Bull 89 2009 23 40
16. C. Powell, C. Mikropoulos, and S.B. Kaye Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers Cancer Treat Rev 36 2010 566 575
17. S.P. Lees-Miller The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight Biochem Cell Biol 74 1996 503 512 (Pubitemid 126734112)
18. K. Sakata, M. Someya, Y. Matsumoto, and M. Hareyama Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity Radiat Med 25 2007 433 438 (Pubitemid 351928005)
19. J. Drouet, C. Delteil, J. Lefrancois, P. Concannon, B. Salles, and P. Calsou DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks J Biol Chem 280 2005 7060 7069 (Pubitemid 40341262)
20. R. Plummer Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target Clin Cancer Res 16 2010 4527 4531
21. M.R. Cookson, P.G. Ince, P.A. Usher, and P.J. Shaw Poly(ADP-ribose) polymerase is found in both the nucleus and cytoplasm of human CNS neurons Brain Res 834 1999 182 185 (Pubitemid 29332028)
22. U. Moll, R. Lau, M.A. Sypes, M.M. Gupta, and C.W. Anderson DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues Oncogene 18 1999 3114 3126 (Pubitemid 29261232)
23. M.L. Cayuela, A. Carrillo, P. Ramirez, P. Parrilla, and J. Yelamos Genomic instability in a PARP-1(-/-) cell line expressing PARP-1 DNA-binding domain Biochem Biophys Res Commun 285 2001 289 294 (Pubitemid 32918068)
24. D.O. Ferguson, J.M. Sekiguchi, and S. Chang The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations Proc Natl Acad Sci USA 97 2000 6630 6633 (Pubitemid 30412765)
25. S.B. Wharton, U. McNelis, H.S. Bell, and I.R. Whittle Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model Neuropathol Appl Neurobiol 26 2000 528 535 (Pubitemid 32049852)
26. K. Kristiansen, S. Hagen, and T. Kollevold Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group Cancer 47 1981 649 652 (Pubitemid 11135858)
27. M. Westphal, D.C. Hilt, and E. Bortey A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 2003 79 88 (Pubitemid 36422560)
28. E.R. Laws, I.F. Parney, and W. Huang Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project J Neurosurg 99 2003 467 473 (Pubitemid 37040405)
29. F.A. Dungey, D.A. Loser, and A.J. Chalmers Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential Int J Radiat Oncol Biol Phys 72 2008 1188 1197
30. F.A. Dungey, K.W. Caldecott, and A.J. Chalmers Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90 Mol Cancer Ther 8 2009 2243 2254
31. M.J. Allalunis-Turner, G.M. Barron, R.S. Day 3rd, K.D. Dobler, and R. Mirzayans Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs Radiat Res 134 1993 349 354 (Pubitemid 23209259)
32. I.H. Ismail, S. Martensson, and D. Moshinsky SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization Oncogene 23 2004 873 882 (Pubitemid 38250932)
33. M. Tavecchio, J.M. Munck, C. Cano, D.R. Newell, and N.J. Curtin Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination Cancer Chemother Pharmacol 2011 [Epub ahead of print]
34. W. Zhuang, B. Li, L. Long, L. Chen, Q. Huang, and Z.Q. Liang Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy Brain Res 1371 2011 7 15
35. M. Frankenberg-Schwager Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionizing radiation Radiother Oncol 14 1989 307 320 (Pubitemid 19136184)
36. M.J. Allalunis-Turner, P.K. Zia, G.M. Barron, R. Mirzayans, and R.S. Day 3rd Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line Radiat Res 144 1995 288 293
37. X. Wang, K. Ohnishi, A. Takahashi, and T. Ohnishi Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation Oncogene 17 1998 2819 2825 (Pubitemid 29010052)
38. J. Mi, J. Dziegielewski, E. Bolesta, D.L. Brautigan, and J.M. Larner Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6 PLoS One 4 2009 e4395
39. J. Gerstein, K. Franz, and J.P. Steinbach Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma Radiother Oncol 97 2010 382 386
40. E.M. Goellner, B. Grimme, and A.R. Brown Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair Cancer Res 71 2011 2308 2317
41. B. McEllin, C.V. Camacho, and B. Mukherjee PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors Cancer Res 70 2010 5457 5464
42. A.L. Russo, H.C. Kwon, and W.E. Burgan In vitro and in vivo radiosensitization of glioblastoma cells by the poly (ADP-ribose) polymerase inhibitor E7016 Clin Cancer Res 15 2009 607 612
43. W.P. Roos, L.F. Batista, and S.C. Naumann Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine Oncogene 26 2007 186 197 (Pubitemid 46095730)